These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 39527305)

  • 1. Prophylactic and therapeutic vaccine development: advancements and challenges.
    Weerarathna IN; Doelakeh ES; Kiwanuka L; Kumar P; Arora S
    Mol Biomed; 2024 Nov; 5(1):57. PubMed ID: 39527305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards personalized vaccines.
    Montin D; Santilli V; Beni A; Costagliola G; Martire B; Mastrototaro MF; Ottaviano G; Rizzo C; Sgrulletti M; Miraglia Del Giudice M; Moschese V
    Front Immunol; 2024; 15():1436108. PubMed ID: 39421749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging artificial intelligence in vaccine development: A narrative review.
    Olawade DB; Teke J; Fapohunda O; Weerasinghe K; Usman SO; Ige AO; Clement David-Olawade A
    J Microbiol Methods; 2024 Sep; 224():106998. PubMed ID: 39019262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring future perspectives and pipeline progression in vaccine research and development.
    Vecchio R; Gentile L; Tafuri S; Costantino C; Odone A
    Ann Ig; 2024; 36(4):446-461. PubMed ID: 38436081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Vaccine Efficacy and Stability: A Review of the Utilization of Nanoparticles in mRNA Vaccines.
    Parvin N; Joo SW; Mandal TK
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in vaccine development for infectious diseases-a Keystone Symposia report.
    Cable J; Graham BS; Koup RA; Seder RA; Karikó K; Pardi N; Barouch DH; Sharma B; Rauch S; Nachbagauer R; Forsell MNE; Schotsaert M; Ellebedy AH; Loré K; Irvine DJ; Pilkington E; Tahtinen S; Thompson EA; Feraoun Y; King NP; Saunders K; Alter G; Moin SM; Sliepen K; Karlsson Hedestam GB; Wardemann H; Pulendran B; Doria-Rose NA; He WT; Juno JA; Ataca S; Wheatley AK; McLellan JS; Walker LM; Lederhofer J; Lindesmith LC; Wille H; Hotez PJ; Bekker LG
    Ann N Y Acad Sci; 2023 Jun; 1524(1):65-86. PubMed ID: 37020354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the journey: A comprehensive review of vaccine development against Klebsiella pneumoniae.
    Douradinha B
    Microbiol Res; 2024 Oct; 287():127837. PubMed ID: 39059097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.
    Chi WY; Hu Y; Huang HC; Kuo HH; Lin SH; Kuo CJ; Tao J; Fan D; Huang YM; Wu AA; Hung CF; Wu TC
    J Biomed Sci; 2024 Oct; 31(1):94. PubMed ID: 39379923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine development for bacterial pathogens: Advances, challenges and prospects.
    Mba IE; Sharndama HC; Anyaegbunam ZKG; Anekpo CC; Amadi BC; Morumda D; Doowuese Y; Ihezuo UJ; Chukwukelu JU; Okeke OP
    Trop Med Int Health; 2023 Apr; 28(4):275-299. PubMed ID: 36861882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment.
    Ankrah PK; Ilesanmi A; Akinyemi AO; Lasehinde V; Adurosakin OE; Ajayi OH
    Cureus; 2023 Oct; 15(10):e46354. PubMed ID: 37920621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized vaccinology: A review.
    Poland GA; Ovsyannikova IG; Kennedy RB
    Vaccine; 2018 Aug; 36(36):5350-5357. PubMed ID: 28774561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvants: current status, research and development, licensing, and future opportunities.
    Cui Y; Ho M; Hu Y; Shi Y
    J Mater Chem B; 2024 May; 12(17):4118-4137. PubMed ID: 38591323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From ancient remedies to modern miracles: tracing the evolution of vaccines and their impact on public health.
    Kajal ; Pandey A; Mishra S
    3 Biotech; 2024 Oct; 14(10):242. PubMed ID: 39319014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on the development of bacterial multi-epitope recombinant protein vaccines via reverse vaccinology.
    Li Y; Farhan MHR; Yang X; Guo Y; Sui Y; Chu J; Huang L; Cheng G
    Int J Biol Macromol; 2024 Oct; 282(Pt 5):136827. PubMed ID: 39476887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine design and development: Exploring the interface with computational biology and AI.
    Ananya ; Panchariya DC; Karthic A; Singh SP; Mani A; Chawade A; Kushwaha S
    Int Rev Immunol; 2024; 43(6):361-380. PubMed ID: 38982912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches.
    Andrew Awuah W; Shah MH; Tan JK; Ranganathan S; Sanker V; Darko K; Tenkorang PO; Adageba BB; Ahluwalia A; Shet V; Aderinto N; Kundu M; Abdul-Rahman T; Atallah O
    CNS Neurosci Ther; 2024 Sep; 30(9):e70013. PubMed ID: 39215399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA vaccines: a new era in vaccine development.
    Chandra S; Wilson JC; Good D; Wei MQ
    Oncol Res; 2024; 32(10):1543-1564. PubMed ID: 39308511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational strategies in Klebsiella pneumoniae vaccine design: navigating the landscape of in silico insights.
    Douradinha B
    Biotechnol Adv; 2024 Nov; 76():108437. PubMed ID: 39216613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA vaccines - a new era in vaccinology.
    Pardi N; Hogan MJ; Porter FW; Weissman D
    Nat Rev Drug Discov; 2018 Apr; 17(4):261-279. PubMed ID: 29326426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.